Literature DB >> 9519832

Examination of determinants for intranuclear localization and transactivation within the RING finger of herpes simplex virus type 1 IE110k protein.

D O'Rourke1, G Elliott, M Papworth, R Everett, P O'Hare.   

Abstract

The herpesvirus regulatory protein IE110k possesses a cysteine-rich, RING finger motif required for its role in transactivation and virus replication. IE110k also localizes to subnuclear compartments termed PODs (PML oncogenic domains). Localization to PODs induces redistribution of the proteins associated with this nuclear compartment, including the cellular RING finger protein, PML. Here we construct a series of deletions, RING domain swaps and point mutations to analyse specific requirements within the IE110k RING finger for subnuclear localization, redistribution of PML and transactivation and we examine the relationship between these activities. We find that IE110k localizes to distinct nuclear subdomains that are more numerous than the cellular PODs and that mutation of two residues within a predicted loop of the RING finger, or replacing the IE110k RING finger with a RING finger from a cellular gene abrogates the ability of IE110k to localize to these extra compartments and traps IE110k in the original PODs. We further demonstrate that RING fingers from the cellular genes mdm-2 and Bmi I, when placed within IE110k, alter the nuclear distribution of IE110k, do not transactivate, and do not redistribute PML. We also demonstrate that the majority of wild-type IE110k, like PML, is associated with the nuclear matrix. Although substitutions and deletions within the RING finger abolish transactivation, these mutant proteins remain tightly associated with the matrix. These results further dissect the determinants involved in different aspects of nuclear compartmentalization of IE110k and are discussed in relation to PML, PODs and the IE110k RING finger.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9519832     DOI: 10.1099/0022-1317-79-3-537

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Nuclear localization and shuttling of herpes simplex virus tegument protein VP13/14.

Authors:  M Donnelly; G Elliott
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture.

Authors:  X p Chen; J Li; M Mata; J Goss; D Wolfe; J C Glorioso; D J Fink
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  ICP0 induces the accumulation of colocalizing conjugated ubiquitin.

Authors:  R D Everett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Development of a novel cell-based assay to monitor the transactivation activity of the HSV-1 protein ICP0.

Authors:  Angela M Fowler; Heather E Shinogle; David J Davido
Journal:  Antiviral Res       Date:  2015-04-30       Impact factor: 5.970

5.  Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.

Authors:  Chris Boutell; Seth Sadis; Roger D Everett
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).

Authors:  Emilia Vanni; Derek Gatherer; Lily Tong; Roger D Everett; Chris Boutell
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

7.  Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1.

Authors:  Michael W Ferenczy; Daniel J Ranayhossaini; Neal A Deluca
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

8.  HSV-1 ICP0: paving the way for viral replication.

Authors:  Miles C Smith; Chris Boutell; David J Davido
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

9.  A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.

Authors:  Chris Boutell; Delphine Cuchet-Lourenço; Emilia Vanni; Anne Orr; Mandy Glass; Steven McFarlane; Roger D Everett
Journal:  PLoS Pathog       Date:  2011-09-15       Impact factor: 6.823

10.  Novel Role for ESCRT-III Component CHMP4C in the Integrity of the Endocytic Network Utilized for Herpes Simplex Virus Envelopment.

Authors:  Tiffany Russell; Jerzy Samolej; Michael Hollinshead; Geoffrey L Smith; Joanne Kite; Gillian Elliott
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.